Clearside Biomedical

+$0.07 (+1.40%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy.

CEO
George M. Lasezkay
Employees
33
Headquarters
Alpharetta, Georgia
Founded
2011

CLSD Key Statistics

Market Cap
291.92M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
833.43K
High Today
$5.20
Low Today
$4.79
Open Price
$5.00
Volume
665.42K
52 Week High
$7.29
52 Week Low
$1.25

CLSD Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure